Finland· FI-REL-REL6569
Beclomet
A beclometasone product, registered in Finland by REMEDA. The same ATC class is registered in 13 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Beclometasone is registered in 13 of 19 countries.
Countries holding a registration under ATC R03BA01 (beclometasone), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Beclometasone · ATC R03BA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of beclometasone costs, country by country.
Normalised to the WHO defined daily dose (0.8 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Beclometasone · price per daily dose (0.8 mg)
USD · FX 28 Sept 2026
- IT Italy$0.49
The record
At a glance
Fimea (Finland)- Manufacturer
- REMEDA
- Country
- Finland (FI)
- ATC code
- R03BA01
- ATC class
- Beclometasone
- Defined daily dose
- 0.8 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
53 interactions on record for beclometasone.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Beclometasone · interactions on record
53 records
- 6 severe
- 28 moderate
- 19 minor
Most severe, free to view
- MifepristoneG03XB01severe
- DesmopressinH01BA02severe
- Dinutuximab betaL01FX06severe
- Brexucabtagene autoleucelL01XL06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R03BA01
Beclometasone, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5d4dc39-cd98-400f-9849-fac652274b79 GET /v1/drugs/e5d4dc39-cd98-400f-9849-fac652274b79?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.8",
"form": "inhalaatioaerosoli",
"route": null,
"ddd_unit": "mg",
"strength": "50 mikrog/annos",
"atc_label": "beklometasoni",
"ma_number": "7610",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL6569",
"authorised_at": "1978-08-30"
}See everything about beclometasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.